SomnoMed Limited announced the introduction of the world's first technology-enabled oral appliance. Whilst reviewing strategy following the World Sleep Meeting in 2019 and during the early parts of the COVID-19 pandemic in 2020, SomnoMed embarked on a development program to address a key limitation of oral appliance therapy ­ a lack of objective data. A large, internally commissioned medical research report highlighted this lack of objective data as a key barrier to prescribing oral appliances.

In response, SomnoMed has set out to deliver a technology solution to the world of oral appliances that will provide this data that has only been available with CPAP devices to date. SomnoMed's aim is to ensure that all treatment stakeholders, including patients, can access overnight data on oral appliance treatment effectiveness. To achieve this, the connected technology will deliver data on both efficacy and compliance, which together determine clinical effectiveness.

This collection of powerful, personalized patient data in oral appliance therapy will inform physicians and dentists, every night, about treatment effectiveness for each of their individual patients.